Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

1.2K
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.2K
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

476
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
476

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary surgical strategies for resection of intracranial gliomas.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Reliability of magnetoencephalography beta desynchronization for language lateralization in a subsequent memory effect paradigm.

Clinical neurophysiology practice·2026
Same author

Health-related quality of life and management routine in painful and painless diabetic polyneuropathy (PREDIP study).

Diabetes research and clinical practice·2026
Same author

IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

Nature cancer·2026
Same author

Tumor-associated epilepsy at diagnosis in glioblastoma patients reveals an inflammatory molecular signature and is associated with better overall survival.

Neuro-oncology·2026
Same author

Long-term endocrine trajectories and reoperation risk after surgery for Rathke's cleft cysts: a single-center cohort study of 177 patients.

Pituitary·2026

Related Experiment Video

Updated: Feb 27, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
09:57

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

Published on: July 13, 2019

13.8K

A New Optimized Percutaneous Access System for CIPII.

Rosa Garcia-Verdugo1, Michael Erbach1, Oliver Schnell1,2

  • 11 Sciarc Institute, Baierbrunn, Germany.

Journal of Diabetes Science and Technology
|June 28, 2017
PubMed
Summary

Continuous intraperitoneal insulin infusion (CIPII) improves glycemic control and quality of life for patients with insulin resistance. The Diaport system offers a promising CIPII delivery method with low side effects and potential for closed-loop integration.

Keywords:
CIPIIhypoglycemiasubcutaneous insulin resistancetype 1 diabetes

More Related Videos

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

1.0K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

Related Experiment Videos

Last Updated: Feb 27, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
09:57

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

Published on: July 13, 2019

13.8K
Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
09:38

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

1.0K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Biomedical Engineering

Background:

  • Subcutaneous insulin resistance poses challenges in diabetes management.
  • Continuous intraperitoneal insulin infusion (CIPII) mimics physiological insulin absorption.
  • CIPII offers improved glycemic control and patient satisfaction.

Purpose of the Study:

  • To evaluate the benefits of CIPII in managing insulin resistance.
  • To highlight the advantages of the Diaport CIPII delivery system.
  • To explore the potential of CIPII in advanced diabetes care.

Main Methods:

  • Review of clinical studies on CIPII therapy.
  • Analysis of patient outcomes with CIPII, focusing on glycemic control and quality of life.
  • Assessment of the Diaport system's efficacy and safety profile.

Main Results:

  • CIPII significantly improves glycemic control.
  • CIPII reduces the frequency of hypoglycemic events.
  • Patients report increased satisfaction and quality of life with CIPII.
  • The Diaport system demonstrates clinical efficacy with minimal side effects.

Conclusions:

  • CIPII is an effective treatment for subcutaneous insulin resistance.
  • The Diaport system is a viable and advantageous CIPII delivery option.
  • CIPII, particularly with systems like Diaport, holds potential for integration into closed-loop diabetes management systems.